{"id":"https://openalex.org/W2802231920","doi":"https://doi.org/10.1080/14656566.2018.1464558","title":"What is the impact of the 2017 cochrane systematic review and meta-analysis that evaluated the use of PCSK9 inhibitors for lowering cardiovascular disease and mortality?","display_name":"What is the impact of the 2017 cochrane systematic review and meta-analysis that evaluated the use of PCSK9 inhibitors for lowering cardiovascular disease and mortality?","publication_year":2018,"publication_date":"2018-04-18","ids":{"openalex":"https://openalex.org/W2802231920","doi":"https://doi.org/10.1080/14656566.2018.1464558","mag":"2802231920","pmid":"https://pubmed.ncbi.nlm.nih.gov/29667439"},"language":"en","primary_location":{"id":"doi:10.1080/14656566.2018.1464558","doi":"https://doi.org/10.1080/14656566.2018.1464558","is_oa":false,"landing_page_url":"https://doi.org/10.1080/14656566.2018.1464558","pdf_url":null,"source":{"id":"https://openalex.org/S52020611","display_name":"Expert Opinion on Pharmacotherapy","issn_l":"1465-6566","issn":["1465-6566","1744-7666"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Pharmacotherapy","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008795111","display_name":"Mohamed A. Jalloh","orcid":"https://orcid.org/0000-0003-0306-9954","observed_orcids":["https://orcid.org/0000-0003-0306-9954","https://orcid.org/0000-0002-3172-2749"]},"institutions":[{"id":"https://openalex.org/I24624658","display_name":"Touro University California","ror":"https://ror.org/0556gk990","country_code":"US","type":"education","lineage":["https://openalex.org/I24624658"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mohamed A. Jalloh","raw_affiliation_strings":["Clinical Sciences, Touro University California College of Pharmacy, Vallejo, CA, USA"],"raw_orcid":"https://orcid.org/0000-0003-0306-9954","affiliations":[{"raw_affiliation_string":"Clinical Sciences, Touro University California College of Pharmacy, Vallejo, CA, USA","institution_ids":["https://openalex.org/I24624658"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048986342","display_name":"Eric J. Ip","orcid":"https://orcid.org/0000-0003-3997-995X","observed_orcids":["https://orcid.org/0000-0003-3997-995X"]},"institutions":[{"id":"https://openalex.org/I24624658","display_name":"Touro University California","ror":"https://ror.org/0556gk990","country_code":"US","type":"education","lineage":["https://openalex.org/I24624658"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric J. Ip","raw_affiliation_strings":["Clinical Sciences, Touro University California College of Pharmacy, Vallejo, CA, USA"],"raw_orcid":"https://orcid.org/0000-0003-3997-995X","affiliations":[{"raw_affiliation_string":"Clinical Sciences, Touro University California College of Pharmacy, Vallejo, CA, USA","institution_ids":["https://openalex.org/I24624658"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061810365","display_name":"Shadi Doroudgar","orcid":"https://orcid.org/0000-0001-8879-7795","observed_orcids":["https://orcid.org/0000-0001-8879-7795"]},"institutions":[{"id":"https://openalex.org/I24624658","display_name":"Touro University California","ror":"https://ror.org/0556gk990","country_code":"US","type":"education","lineage":["https://openalex.org/I24624658"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shadi Doroudgar","raw_affiliation_strings":["Clinical Sciences, Touro University California College of Pharmacy, Vallejo, CA, USA"],"raw_orcid":"https://orcid.org/0000-0001-8879-7795","affiliations":[{"raw_affiliation_string":"Clinical Sciences, Touro University California College of Pharmacy, Vallejo, CA, USA","institution_ids":["https://openalex.org/I24624658"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5008795111"],"corresponding_institution_ids":["https://openalex.org/I24624658"],"apc_list":null,"apc_paid":null,"fwci":0.2515,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.32352941,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"19","issue":"7","first_page":"739","last_page":"741"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pcsk9-inhibitors","display_name":"PCSK9 inhibitors","score":1.0},{"id":"https://openalex.org/keywords/cardiovascular-disease","display_name":"cardiovascular disease","score":0.7509999871253967},{"id":"https://openalex.org/keywords/cardiovascular-mortality","display_name":"cardiovascular mortality","score":0.8999999761581421},{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.9599999785423279},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.9789999723434448},{"id":"https://openalex.org/keywords/ezetimibe","display_name":"ezetimibe","score":0.9980000257492065},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.753000020980835},{"id":"https://openalex.org/keywords/drug-costs","display_name":"drug costs","score":0.414000004529953},{"id":"https://openalex.org/keywords/cholesterol-lowering-therapy","display_name":"cholesterol-lowering therapy","score":0.6610000133514404}],"concepts":[{"id":"https://openalex.org/C2778657065","wikidata":"https://www.wikidata.org/wiki/Q417997","display_name":"Ezetimibe","level":3,"score":0.9380793571472168},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9331740736961365},{"id":"https://openalex.org/C2780948078","wikidata":"https://www.wikidata.org/wiki/Q21130010","display_name":"PCSK9","level":5,"score":0.8035745024681091},{"id":"https://openalex.org/C2780902209","wikidata":"https://www.wikidata.org/wiki/Q4726914","display_name":"Alirocumab","level":5,"score":0.6913594007492065},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.633141815662384},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.5966750383377075},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5257445573806763},{"id":"https://openalex.org/C2776478404","wikidata":"https://www.wikidata.org/wiki/Q1105187","display_name":"Cochrane Library","level":3,"score":0.5160617232322693},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.5055193901062012},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4650477170944214},{"id":"https://openalex.org/C2778114629","wikidata":"https://www.wikidata.org/wiki/Q15623825","display_name":"Evolocumab","level":5,"score":0.41773420572280884},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3687282204627991},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.3008553087711334},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.13752105832099915},{"id":"https://openalex.org/C43554185","wikidata":"https://www.wikidata.org/wiki/Q425649","display_name":"LDL receptor","level":4,"score":0.08589065074920654},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.05900093913078308},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.05422180891036987},{"id":"https://openalex.org/C2780745583","wikidata":"https://www.wikidata.org/wiki/Q1316030","display_name":"Apolipoprotein A1","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000071449","descriptor_name":"Proprotein Convertase 9","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000091362","descriptor_name":"PCSK9 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000091362","descriptor_name":"PCSK9 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000091362","descriptor_name":"PCSK9 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000091362","descriptor_name":"PCSK9 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049674","descriptor_name":"History, 21st Century","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049674","descriptor_name":"History, 21st Century","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049674","descriptor_name":"History, 21st Century","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049674","descriptor_name":"History, 21st Century","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1080/14656566.2018.1464558","doi":"https://doi.org/10.1080/14656566.2018.1464558","is_oa":false,"landing_page_url":"https://doi.org/10.1080/14656566.2018.1464558","pdf_url":null,"source":{"id":"https://openalex.org/S52020611","display_name":"Expert Opinion on Pharmacotherapy","issn_l":"1465-6566","issn":["1465-6566","1744-7666"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Pharmacotherapy","raw_type":"journal-article"},{"id":"pmid:29667439","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29667439","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on pharmacotherapy","raw_type":"Historical Article"},{"id":"pmh:oai:touroscholar.touro.edu:tuccop_pubs-1227","doi":null,"is_oa":false,"landing_page_url":"https://touroscholar.touro.edu/tuccop_pubs/229","pdf_url":null,"source":{"id":"https://openalex.org/S4377196437","display_name":"Touro Scholar (Touro College)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I200437953","host_organization_name":"Touro College","host_organization_lineage":["https://openalex.org/I200437953"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Faculty Publications & Research of the TUC College of Pharmacy","raw_type":"article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8600000143051147}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W1906091442","https://openalex.org/W2164089346","https://openalex.org/W2300129093","https://openalex.org/W2336406314","https://openalex.org/W2511907480","https://openalex.org/W2579473004","https://openalex.org/W2616658146","https://openalex.org/W2758885961","https://openalex.org/W2768588165"],"related_works":["https://openalex.org/W2585426472","https://openalex.org/W2620969414","https://openalex.org/W4281760067","https://openalex.org/W2162657286","https://openalex.org/W2344543776","https://openalex.org/W2046996117","https://openalex.org/W2767163800","https://openalex.org/W3103325438","https://openalex.org/W4311957178","https://openalex.org/W2475508510"],"abstract_inverted_index":{"INTRODUCTION:":[0],"In":[1],"2017,":[2],"Schmidt":[3],"et":[4],"al.":[5],"conducted":[6],"a":[7,39,62,154,161],"Cochrane":[8,36,106,124],"systematic":[9,40],"review":[10,37,41,107,125],"and":[11,31,42,108,119,136,189,196],"meta-analysis":[12,43],"to":[13,26,83,91,95],"evaluate":[14],"the":[15,51,76,103,110,137,143,178],"effect":[16],"of":[17,44,53,65,72,112,139,145,150],"using":[18,158],"proprotein":[19],"convertase":[20],"subtilisin/kexin":[21],"type":[22],"9":[23],"(PCSK9)":[24],"inhibitors":[25,55,74,114,130,152,185],"reduce":[27],"low-density-lipoprotein-":[28],"cholesterol":[29,166],"(LDL-C)":[30],"cardiovascular":[32,117],"disease":[33],"(CVD).":[34],"The":[35,70,99,123,147],"was":[38],"20":[45],"randomized,":[46],"double-blinded":[47],"trials":[48],"that":[49,128],"compared":[50,94],"use":[52,71],"PCSK9":[54,73,113,129,151,184],"with":[56,169],"statins/ezetimibe,":[57],"ezetimibe,":[58],"or":[59],"placebo":[60],"for":[61,78,115,157,163,193],"treatment":[63],"duration":[64],"at":[66],"least":[67],"24":[68],"weeks.":[69],"lowered":[75],"risk":[77,138,144],"CVD":[79,140,195],"(OR":[80,88],"0.86":[81],"(0.80":[82],"0.92))":[84],"but":[85,141],"not":[86,142],"mortality":[87],"1.02":[89],"(0.91":[90],"1.14))":[92],"when":[93],"placebo.":[96],"Areas":[97],"covered:":[98],"following":[100],"article":[101],"evaluates":[102],"recently":[104],"published":[105],"clarifies":[109],"efficacy":[111,192],"improving":[116],"morbidity":[118],"mortality.":[120,146,174,197],"Expert":[121],"opinion:":[122],"discussed":[126],"suggests":[127],"are":[131],"effective":[132],"in":[133],"lowering":[134,167],"LDL-C":[135],"higher":[148],"price":[149],"is":[153],"further":[155],"deterrent":[156],"them":[159],"as":[160],"substitute":[162],"statins":[164],"-":[165],"medications":[168],"history":[170],"showing":[171],"they":[172],"lower":[173],"Statins":[175],"should":[176],"remain":[177],"gold-standard":[179],"cholesterol-lowering":[180],"drug":[181],"class":[182],"until":[183],"become":[186],"more":[187],"affordable":[188],"demonstrate":[190],"consistent":[191],"reducing":[194]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2}],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2025-10-10T00:00:00"}